TCRX
Tscan Therapeutics Inc
0.2769$
+0.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 7.5% | – | 2,004.5% | 750.2% | 362.1% | 379.2% | 589.0% | 441.8% | 486.3% | 357.3% | 37.2% | 47.9% | 22.0% | 41.2% | 33.1% | 17.8% | 221.6% | 208.2% | 97.9% | 106.9% | – | – | 30.5% | 28.2% | 70.6% | – | – | |
| -7.5% | – | -1,904.5% | -650.2% | -262.1% | -279.2% | -489.0% | -341.8% | -386.3% | -257.3% | 100.0% | 52.1% | 100.0% | 100.0% | 100.0% | 82.2% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 29.4% | 100.0% | 90.3% | |
| 7.5% | – | 2,004.5% | 750.2% | 362.1% | 379.2% | 589.0% | 441.8% | 486.3% | 357.3% | 447.0% | 504.2% | 320.1% | 674.3% | 585.1% | 310.7% | 4,391.7% | 5,014.4% | 2,503.5% | 4,414.1% | 1,372.1% | 1,060.9% | 1,262.0% | 780.6% | 2,230.5% | 2,226.6% | 1,364.6% | |
| 2.3% | – | 568.3% | 332.2% | 128.6% | 95.7% | 167.8% | 155.9% | 148.8% | 118.5% | 146.0% | 198.4% | 114.2% | 207.5% | 151.6% | 85.5% | 1,219.4% | 1,416.0% | 706.3% | 1,097.0% | 389.5% | 290.0% | 306.6% | 223.2% | 836.8% | 774.7% | 418.9% | |
| 2.3% | – | 568.3% | 332.2% | 128.6% | 95.7% | 167.8% | 155.9% | 148.8% | 118.5% | 593.0% | 654.6% | 434.3% | 881.8% | 736.7% | 378.4% | 5,642.9% | 6,464.6% | 3,209.8% | 5,620.6% | 1,769.7% | 1,356.6% | 1,575.6% | 1,029.4% | 2,996.7% | 3,001.3% | 1,785.4% | |
| -9.8% | – | -2,472.8% | -982.4% | -390.6% | -375.0% | -656.8% | -497.6% | -535.0% | -375.9% | -493.0% | -602.6% | -334.3% | -781.8% | -636.7% | -296.2% | -5,542.9% | -6,364.6% | -3,109.8% | -5,520.6% | -1,669.7% | -1,256.6% | -1,475.6% | -929.4% | -2,967.3% | -2,901.3% | -1,695.1% | |
| – | – | – | 0.4% | – | – | – | 0.1% | 0.2% | 3.7% | 6.0% | 31.5% | 14.1% | 30.8% | 25.3% | 11.8% | 169.4% | 177.6% | 91.3% | 117.9% | 31.3% | 22.4% | 27.8% | 27.3% | 70.2% | 66.5% | 39.2% | |
| -9.6% | – | -2,472.4% | -982.0% | -390.3% | -374.8% | -656.7% | -497.5% | -534.8% | -372.2% | -483.1% | -604.9% | -331.7% | -763.8% | -591.6% | -272.0% | -5,325.4% | -5,906.9% | -2,849.1% | -5,384.8% | -1,571.9% | -1,201.3% | -1,422.1% | -895.1% | -2,919.1% | -2,888.6% | -1,655.4% | |
| -0.2% | – | -0.3% | -0.8% | -0.3% | -0.2% | -0.1% | -0.1% | -0.2% | -3.7% | 15.9% | 2.4% | 16.1% | 48.7% | -33.1% | -14.2% | -221.6% | -208.2% | – | 188.6% | – | – | – | – | – | – | – | |
| -9.6% | – | -2,472.4% | -982.0% | -390.3% | -374.8% | -656.7% | -497.5% | -534.8% | -372.2% | -483.1% | -604.9% | -331.7% | -763.8% | -591.6% | -272.0% | -5,325.4% | -5,906.9% | -2,849.1% | -5,384.8% | -1,571.9% | -1,201.3% | -1,422.1% | -895.1% | -2,919.1% | -2,888.6% | -1,655.4% | |
| -9.4% | – | -2,353.4% | -932.6% | -367.5% | -351.6% | -612.9% | -457.5% | -495.2% | -342.5% | -439.9% | -525.5% | -295.6% | -691.9% | -533.3% | -242.4% | -4,934.5% | -5,521.1% | -2,659.9% | -5,160.0% | -1,509.4% | -1,156.2% | -1,363.8% | -839.6% | -2,778.4% | -2,755.6% | -1,575.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.